Sunday, October 1, 2023
News Media Empire
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
News Media Empire
No Result
View All Result
Home Health

Moderna doesn’t plan to share COVID-19 vaccine recipe with world, chairman says – National | Globalnews.ca

October 11, 2021
in Health
0
Moderna doesn’t plan to share COVID-19 vaccine recipe with world, chairman says - National | Globalnews.ca
0
SHARES
Share on FacebookShare on TwitterShare on RedditShare on Whatsapp


Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman said Monday.

In an interview with The Associated Press, Noubar Afeyan also reiterated a pledge Moderna made a year ago not to enforce patent infringement on anyone else making a coronavirus vaccine during the pandemic.

Get Free Advertise Coin

“We didn’t have to do that,” Afeyan said. ”We think that was the responsible thing to do.” He added: “We want that to be helping the world.”

Read more:
Exclusive look inside Moderna: Tracking variants and the call for COVID-19 boosters

The United Nations health agency has pressed Moderna to share its vaccine formula. Afeyan said the company analyzed whether it would be better to share the messenger RNA technology and determined that it could expand production and deliver billions of additional doses in 2022.

Story continues below advertisement

“Within the next six to nine months, the most reliable way to make high-quality vaccines and in an efficient way is going to be if we make them,” Afeyan said. Asked about appeals from the World Health Organization and others, he contended that such pleas assumed ”that we couldn’t get enough capacity, but in fact we know we can.”


Click to play video: 'Moderna asks Health Canada to approve COVID-19 vaccine booster shot'






2:06
Moderna asks Health Canada to approve COVID-19 vaccine booster shot


Moderna asks Health Canada to approve COVID-19 vaccine booster shot

Moderna “went from zero production to having 1 billion doses in less than a year,” Afeyan said, referring to the Massachusetts-based company’s sprint to develop the vaccine and produce it in large quantities. “And we think we will be able to go from 1 to 3 billion” in 2022.

The COVID-19 vaccine is Moderna’s only commercial product. The company announced plans last week to open a vaccine plant somewhere in Africa. Afeyan said he hopes a decision will be made soon on an exact location. Still, it could take years to get the plant up and running.

Story continues below advertisement

Read more:
Canadians may need COVID-19 boosters by Christmas, Moderna president says

Afeyan spoke on the last full day of a visit to Italy in which he met Pope Francis, who has appealed for universal vaccine access. He also appeared in Venice to promote a humanitarian prize initiative.


View link »





© 2021 The Canadian Press





Source link

Tags: COVIDcovid vaccinecovid-19COVID-19 VaccineHealthmodernaModerna Covidmoderna covid vaccineModerna COVID-19 Vaccinemoderna vaccineModerna. COVID-19Vaccine ModernaWorld
Previous Post

Narine stars as Kolkata end captain Kohli’s IPL dream | Sport

Next Post

Thailand to re-open to vaccinated tourists from November | Fin24

Related Posts

Want to sleep like Blue Jays pitcher Yusei Kikuchi? Here's what one expert suggests | CBC Radio
Health

Want to sleep like Blue Jays pitcher Yusei Kikuchi? Here’s what one expert suggests | CBC Radio

October 1, 2023
Children once had their spines checked in Canada. These experts want to bring it back | CBC News
Health

Children once had their spines checked in Canada. These experts want to bring it back | CBC News

October 1, 2023
Student violence on teachers is a growing concern. What can be done? - National | Globalnews.ca
Health

Student violence on teachers is a growing concern. What can be done? – National | Globalnews.ca

September 30, 2023
Next Post
Phuket.

Thailand to re-open to vaccinated tourists from November | Fin24

Israel a step closer to commercial drones with latest tests

Israel a step closer to commercial drones with latest tests

Gov. Inslee should extend deadline for long-term-care insurance

Gov. Inslee should extend deadline for long-term-care insurance

Discussion about this post

AdvertiseCoin ADCO Get Now Free
News Media Empire

Newsmediaempire is an online news source that provides the latest news and other information about everything that you must need to know. It publishes news related to various fields like world, business, sports, politics, tech, health, lifestyle, and other different exclusive stories.

Let's connect!

Categories

  • Business & Economy
  • Crypto
  • Entertainment
  • Health
  • Lifestyle
  • Money
  • Opinion
  • Politics
  • Science & Tech
  • Sports
  • World News

Recent News

  • Exact date £300 cost of living payments will reach bank accounts from DWP October 1, 2023
  • Gemini Eyes Revised Proposal in Latest Update in Feud With DCG October 1, 2023
  • Bride 'can't speak' and groom is 'dead inside' after Iraq wedding fire kills family October 1, 2023

Join Our Newsletter!

    • About Us
    • Contact
    • Privacy Policy
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    No Result
    View All Result
    • About Us
    • Contact
    • Home 1
    • Home 2
    • Home 3
    • Privacy Policy
    • Random
    • Sample Page
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    en English
    ar Arabicbg Bulgarianzh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.